Hims & Hers Health Profit Margin 2020-2025 | HIMS
Current and historical gross margin, operating margin and net profit margin for Hims & Hers Health (HIMS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Hims & Hers Health net profit margin as of September 30, 2025 is 6.05%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.555B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $31.346B | 36.25 |
| Tempus AI (TEM) | United States | $9.527B | 0.00 |
| Doximity (DOCS) | United States | $6.637B | 27.33 |
| IRhythm Holdings (IRTC) | United States | $4.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.707B | 169.31 |
| Hinge Health (HNGE) | United States | $2.617B | 0.00 |
| 10x Genomics (TXG) | United States | $2.412B | 0.00 |
| Heartflow (HTFL) | United States | $2.396B | 0.00 |
| Omnicell (OMCL) | United States | $2.095B | 42.83 |
| Inspire Medical Systems (INSP) | United States | $1.983B | 32.80 |
| Azenta (AZTA) | United States | $1.310B | 52.76 |
| Enovis (ENOV) | United States | $1.304B | 6.85 |
| Clover Health Investments (CLOV) | United States | $1.090B | 0.00 |
| Schrodinger (SDGR) | United States | $0.984B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.927B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.789B | 0.00 |
| Phreesia (PHR) | United States | $0.773B | 0.00 |
| Talkspace (TALK) | United States | $0.644B | 129.67 |
| Standard BioTools (LAB) | United States | $0.492B | 0.00 |
| Claritev (CTEV) | United States | $0.416B | 0.00 |
| Evolent Health (EVH) | United States | $0.342B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.331B | 15.21 |
| Carlsmed (CARL) | United States | $0.306B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.295B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.243B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.236B | 0.00 |
| CapsoVision (CV) | United States | $0.234B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.190B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.159B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.153B | 0.00 |
| CareCloud (CCLD) | United States | $0.103B | 5.67 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| American Well (AMWL) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| HeartBeam (BEAT) | United States | $0.048B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.040B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.016B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.014B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Zhongchao (ZCMD) | China | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |